Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Boehringer Ingelheim
Harvard Business School
Medtronic
Moodys

Last Updated: December 11, 2019

DrugPatentWatch Database Preview

FORTAZ Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Which patents cover Fortaz, and what generic alternatives are available?

Fortaz is a drug marketed by Teligent and is included in two NDAs.

The generic ingredient in FORTAZ is ceftazidime sodium. There are seventeen drug master file entries for this compound. Additional details are available on the ceftazidime sodium profile page.

Drug patent expirations by year for FORTAZ
Pharmacology for FORTAZ
Synonyms for FORTAZ
(6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl}amino)-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(1-hydroxy-2-methyl-1-oxopropan-2-yl)oxyiminoacetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(1-hydroxy-2-methyl-1-oxopropan-2-yl)oxyiminoacetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate pentahydrate
(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(2-carboxypropan-2-yloxyimino)-1-oxoethyl]amino]-8-oxo-3-(1-pyridin-1-iumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate pentahydrate
(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(1-carboxy-1-methyl-ethoxy)imino-acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate pentahydrate
1-(((6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)pyridinium hydroxide, inner salt, 7(sup 2)-(Z)-(O-(1-carboxy-1-methylethyl)oxime), pentahydrate
1-{[(6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetamido]-2-carboxylato-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}pyridin-1-ium
72558-82-8
78439-06-2
7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-3-(pyridinium-1-ylmethyl)-3,4-didehydrocepham-4-carboxylate
7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-3-(pyridinium-1-ylmethyl)-3,4-didehydrocepham-4-carboxylate--water (1/5)
A-7878
A839420
AB00513848
AB00513848-02
AB1009357
AC1NUK7U
AC1O6W4W
AKOS015951273
AKOS027327285
AN-37419
BDBM50420259
BIDD:GT0734
C06889
C22H22N6O7S2
C22H22N6O7S2.5H2O
C22H23N6O7S2.HO
CAS-78439-06-2
CAZ
CCG-220489
Cefprozil, Antibiotic for Culture Media Use Only
Ceftazidim
ceftazidima
Ceftazidima [INN-Spanish]
ceftazidime
CEFTAZIDIME (ARGININE FORMULATION)
Ceftazidime (contains ca. 10% Na2CO3)
Ceftazidime (INN)
Ceftazidime (TN)
Ceftazidime (USP)
Ceftazidime [USAN:INN:BAN:JAN]
Ceftazidime anhydrous
Ceftazidime hydrate
Ceftazidime hydrate (JP17)
Ceftazidime hydrate, >=90.0%, contains 10% sodium carbonate as stabilizer
Ceftazidime pentahydrate
Ceftazidime pentahydrate (contains ca. 10% Na2CO3)
Ceftazidime Sodium In Plastic Container
ceftazidimum
Ceftazidimum [INN-Latin]
Ceptaz
Ceptaz (TN)
CHEBI:3508
CHEBI:3509
CHEMBL3186392
CHEMBL44354
CS-2810
D00921
D07654
DB00438
DSSTox_CID_25599
DSSTox_GSID_45599
DSSTox_RID_80992
DTXSID0045599
DTXSID5022770
Fortam
Fortaz (TN)
Fortaz In Plastic Container
Fortum
Glazidim
GR 20263
GR-20263
HMS2090M13
HMS2096B19
HMS3713B19
HY-B0593
LS-132195
LY 139381
LY-139381
Modacin
MolPort-006-137-763
MolPort-020-001-272
NCGC00017137-01
NMVPEQXCMGEDNH-NLYPMKEPSA-N
Pentacef
Pyridinium, 1-((7-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, hydroxide, inner salt, (6R-(6-alpha,7-beta(Z)))-, pentahydrate
Pyridinium, 1-((7-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, hydroxide, inner salt, pentahydrate, (6R-(6alpha,7beta(Z)))-
Pyridinium, 1-((7-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, hydroxide, inner salt,(6R-(6-alpha,7-beta(Z)))-, pentahydrate
Pyridinium, 1-((7-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, pentahydrate, (6R-(6alpha,7beta(Z)))-
Q-200811
SCHEMBL36849
SN 401 pentahydrate
Spectrum
Tazicef
Tazicef (TN)
Tazidime
Tazidime In Plastic Container
Tox21_110797

US Patents and Regulatory Information for FORTAZ

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teligent FORTAZ ceftazidime INJECTABLE;INJECTION 050578-002 Jul 19, 1985 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Teligent FORTAZ IN PLASTIC CONTAINER ceftazidime sodium INJECTABLE;INJECTION 050634-003 Apr 28, 1989 DISCN Yes No   Start Trial   Start Trial   Start Trial
Teligent FORTAZ ceftazidime INJECTABLE;INJECTION 050578-001 Jul 19, 1985 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Teligent FORTAZ ceftazidime INJECTABLE;INJECTION 050578-003 Jul 19, 1985 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Teligent FORTAZ ceftazidime INJECTABLE;INJECTION 050578-004 Jul 19, 1985 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Teligent FORTAZ IN PLASTIC CONTAINER ceftazidime sodium INJECTABLE;INJECTION 050634-002 Apr 28, 1989 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
AstraZeneca
Boehringer Ingelheim
Johnson and Johnson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.